spacer
home > epc > spring 2018 > early beginnings
PUBLICATIONS
European Pharmaceutical Contractor

Early Beginnings

Moving a promising drug candidate from the laboratory to first-in-human (FIH) trials is a complex, multistage challenge. Coordinating the formulation development steps, manufacturing, and logistics involved requires careful management and planning.

Integrating the process in collaboration with expert vendors offers drug developers an efficient, cost-effective pathway to success in early phase development. Furthermore, experienced contractors can help drug companies avoid the early phase pitfalls that can see projects fail at a later stage.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
1
     

There are no comments in regards to this article.

spacer
Dr Torkel Gren is General Manager at Recipharm Pharmaceutical Development. Torkel holds degrees in pharmacy and business administration, as well a PhD in Pharmaceutics from Uppsala University, Sweden. He has worked in the pharma industry since 1988 and has held a number of scientist and manager positions in Europe and the US. Torkel was lead formulator and co-inventor of Detrol OD/Detrusitol SR. He is a member of the board of the Swedish Pharmaceutical Society.

Anders Millerhovf is CEO at CTC Clinical Trial Consultants. He holds a degree in medical biology from Linköping University, Sweden. Anders has worked in the life sciences industry since 2002 and has been focused on Phase 0-2a projects in various management and director positions. He has been a partner at CTC since 2012.
spacer
Dr Torkel Gren
spacer
spacer
spacer
Anders Millerhovf
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

rfxcel Covers the Cost of EMVO Onboarding Fees

May 23, 2018 - San Ramon, CA – rfxcel Corporation, a technically certified Gateway Provider for the European Medicines Verification Organisation (EMVO) announced today that it will pay the cost of statutory fees payable to EMVO* for all manufacturers (Marketing Authorisation Holders, MAHs) which select rfxcel as their Gateway Provider before June 15th 2018.
More info >>

White Papers

How To Increase Efficiency, Customer Satisfaction and Reduce Cost

AC Labels

A customer of Riverside Medical had required a complex four-part 'piggy back' label. The labels needed to be specially constructed to facilitate removal in parts at various stages of its use for quality control traceability. This label needed to carry variable data elements of LOT numbers, batch numbers and product descriptions, and also a secondary gamma indicator label placed on each of its 4 sections to prove its sterility following sterilisation.
More info >>

 
Industry Events

SMi’s 5th Molecular Diagnostics Conference

9-11 July 2018, Holiday Inn Kensington Forum, London, UK

SMi is proud to announce their 5th Molecular Diagnostics conference. The event will take place in central London on Monday 9th and Tuesday 10th July 2018, along with two half-day post-conference workshops taking place on Wednesday 11th July 2018
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement